LungBlog

LUNG cancer kills more Americans than any other type of malignancy, claiming 162,000 lives every year. It is responsible for nearly one-third of all cancer deaths, yet, as the death toll climbs, research funding for this ferocious killer is lower than any other major cancer.

ImClone Systems Incorporated is conducting a clinical trial for patients whose non-small cell lung cancer has recurred or continued to advance despite previous treatment. The goal of the trial is to compare the progression-free survival of patients treated with ERBITUX^® (cetuximab) and Alimta^® (pemetrexed) to progression-free survival of patients treated with three other combination chemotherapy regimens including TAXOTERE^® (docetaxel).

Research published today in Science Express from the journal Science demonstrates the first definitive link between mutations in the gene DICER1 and cancer. By studying the patterns of DNA from 11 families with an unusual predisposition to the rare childhood lung cancer pleuropulmonary blastoma (PPB) investigators found that children with the cancer carried a mutation in one of their two DICER1 gene copies.

GIA announces the release of a comprehensive global report on Lung Cancer Therapeutics market. World market for non-small cell lung cancer therapeutics is expected to reach $13.3 billion by 2015 fueled by rising incidence of lung cancer, improved understanding of non-small cell lung cancer, and the development of new treatments targeted at growth factor pathways.

Lung cancer is the leading cause of death from cancer worldwide. Conventional studies mainly think that insulin-like growth factor-I ( IGF-I ) and IGF-binding protein-3(IGFBP-3) may promote and inhibit tumor growth, respectively.

The federal government can now regulate the amount of nicotine in tobacco products, ban flavorful additives, require every chemical ingredient to be detailed on the label and prohibit deceptive marketing and ads that target the young.

Lung Cancer Alliance President Laurie Fenton-Ambrose said, “This puts us on a whole new track in helping current smokers to quit and in preventing new generations of young people from ever becoming addicted in the first place.”

“The largest study of its kind has unexpectedly concluded that smoking marijuana, even regularly and heavily, does not lead to lung cancer.”

“Donald Tashkin of the University of California at Los Angeles, a pulmonologist, expected a positive association between marijuana use and lung cancer.  There was no association at all, and even a suggestion of some protective effect.

Nearly 2500 households in Broxtowe received free test for radon gas after an offer from the borough council.

Radon is a naturally occurring gas, which is known to increase the risk of developing lung cancer.

The 10 most commonly diagnosed cancers among men in the United States* included cancers of the prostate, lung, colon and rectum, and bladder; melanomas of the skin; non-Hodgkin lymphoma; kidney cancer, mouth and throat cancer, leukemias, and pancreatic cancer.

Field Fisher Waterhouse LLP has won £84,000 in compensation for Mr B, a 67 year old man from Hayes who contracted lung cancer after being exposed to asbestos dust whilst working as a labourer for Cape Building Products Limited in the 1960s.

During his 18 months at Cape Building Products, Mr B was heavily exposed to asbestos dust in the course of his work. His tasks included handling sacks of raw asbestos which he was required to open and empty out.